High fat-induced obesity associated with insulin-resistance increases FGF-2 content and causes stromal hyperplasia in rat ventral prostate.
Obesity affects sex hormone secretion, which can negatively influence prostatic structure, homeostasis, and disease. This investigation aimed to evaluate the repercussions of obesity induced by a high-fat diet on the rat prostate, with or without treatment with the aromatase inhibitor, Letrozole. Adult Wistar rats were fed a high-fat diet (20% saturated fat, O) for 15 weeks to induce obesity or received a balanced diet (4% fat, C). Then, a group of C and O rats were daily treated with Letrozole (1 mg/kg b.w. per day) for 2 weeks (CL and OL, respectively). Subsequently, ventral prostate was processed for analysis by transmission electron microscopy, immunohistochemistry, and Western blotting. Obesity decreased 70% of the testosterone plasma level. The prostate showed epithelial atrophy and dilated acini in the intermediate portion and epithelial wrinkling in the distal tips. The relative frequency of smooth muscle α-actin in the O group increased by 67%. Ultrastructurally, epithelial cells in obese animals presented altered secretory organelles, lipid droplets, and thicker subjacent fibromuscular layer. Letrozole treatment caused a partial restoration of the prostatic changes caused by obesity. Obesity increased the prostatic content of fibroblast growth factor-2 (FGF-2) by 150%, and Letrozole treatment increased this protein even more in the control and obese groups. This investigation shows that obesity provokes structural and ultrastructural changes in the epithelium of rat prostate; these changes might affect gland homeostasis and physiology. The epithelial and smooth muscle cell hyperplasia and increased FGF-2 expression observed in this experimental model of obesity/insulin-resistance might explain the high frequency of benign prostatic hyperplasia in insulin-resistant men.
Department of Histology, Institute of Biomedical Sciences, Federal University of Uberlandia, Uberlândia, Minas Gerais, Brazil.
Daniele Lisboa
DL
Ribeiro
Maria Etelvina
ME
Pinto
Samantha Yuri
SY
Maeda
Sebastião Roberto
SR
Taboga
Rejane Maira
RM
Góes
D000818:Animals; D003094:Collagen / Q000032:analysis; D059305:Diet, High-Fat; D004041:Dietary Fats / Q000009:adverse effects* / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000032:analysis / Q000378:metabolism*; D006965:Hyperplasia / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D007333:Insulin Resistance; D008297:Male; D009765:Obesity / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D011467:Prostate / Q000378:metabolism / Q000473:pathology*; D051381:Rats; D017208:Rats, Wistar
D004041:Dietary Fats; D016222:Fibroblast Growth Factor 2; D003094:Collagen